Submitting Patient-Reported Outcome Data in Cancer Clinical Trials
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 6, 2023
November 3, 2023
cdd19350-5c19-44b6-9812-51398fa0fc71
Related Documents
Submitting Continuous Glucose Monitoring Data in Clinical Trials
Guidance DocumentMay 6, 2026Center for Biologics Evaluation and Research
Technical Specifications for Submitting Clinical Trial Data Sets for Response Assessments for Treatments of Acute Leukemias: Guidance for Industry Technical Specifications Document
Guidance DocumentOctober 14, 2025Office of the Commissioner
Submitting Clinical Trial Datasets and Documentation for Clinical Outcome Assessments Using Item Response Theory
Guidance DocumentNovember 6, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox